What if you'd held NAMS?
A $1,000 investment in NewAmsterdam Pharma Company N.V. (NAMS) at the month-end close of 2021-02 would be worth $2,792 at the close of 2026-08 — +179.2% total return, dividends reinvested. The same $1,000 in the S&P 500 would be worth $2,022.
Your scenario
Result
If you'd bought $1,000 at the start of each year
Value of $1,000 invested on January 1 of each year, held to 2026-08, dividends included.
Every year, $1,000 from 2021
| Year | Value of $1,000 | Year return |
|---|---|---|
| 2021 | $1,000 | — |
| 2022 | $1,118 | +11.8% |
| 2023 | $1,146 | +2.5% |
| 2024 | $2,636 | +130.1% |
| 2025 | $3,598 | +36.5% |
| 2026 | $2,926 | -18.7% |
Best and worst month-end to buy
The best single month-end close to have bought NAMS was 2022-11 ($8.10): $1,000 then is $3,522 today. The worst was 2025-11 ($41.30): $1,000 then is $691.
FAQ
What would $1,000 in NAMS be worth today?
A $1,000 investment in NewAmsterdam Pharma Company N.V. (NAMS) at the start of 2021 would be worth about $2,792 today, a total return of +179.2%. Dividends are reinvested in these figures.
What were the best and worst years for NAMS?
NewAmsterdam Pharma Company N.V. (NAMS)'s strongest calendar year since 2021 was 2024, a +130.1% return — $1,000 held through that year became about $2,301 by year-end. Its weakest year was 2026, at -18.7%.
Does the calculator include dividends and splits?
Yes where available. Prices are adjusted for both stock splits and reinvested dividends (total return), the same measure brokerages use.
How much would $100 per month in NAMS have grown?
Investing $100 at the end of every month since 2021-02 would have grown to about $13,610 on $6,700 invested.
Did NAMS beat the S&P 500?
Over the same period, $1,000 in the S&P 500 index would be worth $2,022. NAMS beat the S&P 500 by +38.0% in total return.
Is this investment advice?
No. Wall Street Regrets is an entertainment and education tool. Every number is a historical calculation, not a prediction, and past performance never guarantees future results.
Methodology
NewAmsterdam Pharma Company N.V. (NAMS) historical total-return data from 2021-02 to 2026-08, reduced to month-end closes for the tables above.
Returns use adjusted close prices from Yahoo Finance historical data — adjusted for stock splits and reinvested dividends — the same convention used by major brokerages. A "year" scenario invests $1,000 at the prior December's month-end close and values it at the latest available month-end close. Non-USD amounts are converted at historical month-end exchange rates (Yahoo Finance): to USD on the buy date and back to your currency at the latest rate, so the return reflects the currency move as well as the asset.
Month-end resolution means intra-month extremes are not captured in tables; the calculator uses exact trading-day closes where daily data is available. Figures ignore taxes, fees, and the currency effects of non-USD listings. History is not a forecast. Wall Street Regrets is entertainment, not investment advice.
What if you'd held…
Data: adjusted close prices via Yahoo Finance. As of 2026-08. Not financial advice.